Cite
HARVARD Citation
Bell, J. et al. (n.d.). P1–351: A novel BACE inhibitor (PF‐05297909): A two‐part adaptive design to evaluate safety, pharmacokinetics and pharmacodynamics for modifying beta‐amyloid in a first‐in‐human study. Alzheimer's & dementia. p. P287. [Online].